Home
/
Treatment
/
(S)-8-{2-Amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester

(S)-8-{2-Amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester

	(S)-8-{2-Amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester
Trade Name
Orphan Indication	Pulmonary Arterial Hypertension
USA Market Approval	USA
USA Designation Date	2015-10-06 00:00:00
Sponsor	Roivant Sciences GmbH;8 Viaduktstrasse;Basel

Related Access Program

Pfizer – Pulmonary Arterial Hypertension (PAH) Pfizer – Pulmonary Arterial Hypertension Bayer – Pulmonary arterial hypertension